Literature DB >> 12170004

Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report.

Carlos A Garcia1, Richard P Spencer.   

Abstract

Osteoporosis associated with aging is considered the most common cause of bone mineral loss. Osteomalacia, abnormal bone loss with excess osteoid formation, is another cause. A 46-year-old man was examined for chronic hip and lower extremity pain that had not been relieved by nonsteroidal anti-inflammatory drugs or steroids. A bone scan revealed multiple foci of activity. The serum calcium level was normal, but phosphorus values were low. These results did not correspond with the indications for typical hyperparathyroid disease, so another cause was sought. An In-111 octreotide scan showed a focus in the right humeral head. At surgery, a phosphaturic tumor of mesenchymal origin was partially resected. Oncogenic osteomalacia is related to secretion of a phosphaturic material from a fibroblast growth factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170004     DOI: 10.1097/00003072-200208000-00007

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  18 in total

1.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

2.  Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients.

Authors:  Chi Long Ho
Journal:  Nucl Med Mol Imaging       Date:  2015-03-25

3.  Tumor-induced osteomalacia.

Authors:  Mala Kaul; Miriam Silverberg; Edward F Dicarlo; Robert Schneider; Anne R Bass; Doruk Erkan
Journal:  Clin Rheumatol       Date:  2007-01-16       Impact factor: 2.980

Review 4.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

5.  Imaging features of phosphaturic mesenchymal tumors.

Authors:  Stephen M Broski; Andrew L Folpe; Doris E Wenger
Journal:  Skeletal Radiol       Date:  2018-07-09       Impact factor: 2.199

6.  Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.

Authors:  Deng-Huang Su; Kuo-Meng Liao; Ying-Chun Chang; Keh-Sung Tsai
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Using (18)F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia.

Authors:  Hyo Jung Seo; Yun Jung Choi; Hyun Jeong Kim; Yong Hyu Jeong; Arthur Cho; Jae Hoon Lee; Mijin Yun; Jong Doo Lee; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2011-07-14

8.  Glomus tumor as a cause of oncogenic osteomalacia.

Authors:  Mehdi Dehghani; Mohammad Hossien Dabbaghmanesh; Abolfazele Khalafi-Nezhad; Nader Riazmontazer; Amireza Dehghanian; Reza Vojdani; Mohammadreza Sasani
Journal:  Clin Cases Miner Bone Metab       Date:  2017-12-27

9.  Osteomalacia.

Authors:  Michael Maricic
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

Review 10.  Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region.

Authors:  Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Head Neck Pathol       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.